Experts are providing guidance on managing complications related to cirrhosis, including ascites and hyponatremia. Research is also exploring potential new treatments, such as recombinant albumin and namodenoson, which may improve outcomes for patients with decompensated liver cirrhosis. The field of cirrhosis and ascites care is expected to continue evolving in 2025 and beyond.